Given growing initiatives incentivizing academic researchers to engage in ‘entrepreneurial’ activities, this article examines how these academic entrepreneurs claim value in their entrepreneurial engagements, and navigate concerns related to conflicts of interest. Using data from qualitative...

Biotechnology companies can access financial and management resources through venture capitalist (VC) firms. An analysis of 1,490 VC investments shows that country-of-origin (CO) of biotech companies has an effect on the participation by VC firms in various biotech subsectors. Specifically, it...

This chapter focuses on ethical issues raised by the use of artificial intelligence (AI) in the do-main of health. In particular we discuss specific issues in biomedical research, healthcare provision and public health. We devote particular attention to ethical concerns about safety and evidence...

It is now widely acknowledged that biotechnology will have significant implications for development. While biotechnology's potential for low income economies is still the subject of controversy, this paper argues that it is precisely in these countries that food and agriculture related...

Managers of biotechnology companies face great technological and market risks in making investment decisions. Traditional investment decision tools such as the discounted cash flow (DCF) approaches are often deemed insufficient in the face of the highly uncertain environment surrounding...

Prior research on corporate headquarters (CHQ) characteristics identifies the impact of CHQ location and composition on the innovation outcomes of internal subsidiaries. However, given that external strategic alliances with high-tech entrepreneurial firms represent a key source of innovation for...